Market Place
Sourcing Support
AbbVie buys Roche spinout Nimble Therapeutics for $200M
14 Dec 2024 //
PRESS RELEASE
Nimble Announces Formation of a World-Class Scientific Advisory Board
11 Jun 2024 //
BUSINESSWIRE
Nimble Expands its Drug Discovery Capabilities to Advance Pipeline to the Clinic
03 Apr 2024 //
BUSINESSWIRE
Nimble Adds Peptide Drug Development Expertise to BOD
19 Mar 2024 //
BUSINESSWIRE
Roche further taps drug discovery spinout in $1.1B biobucks deal
06 Jan 2023 //
FIERCE BIOTECH
Nimble Therapeutics Announces Expansion of its Partnership with Genentech
05 Jan 2023 //
BUSINESSWIRE
Nimble Delivers Compounds for Programs Under Collaboration with Pharma Partner
13 Dec 2022 //
BUSINESSWIRE
Nimble Therapeutics names Pete Gough as Chief Scientific Officer
30 Nov 2022 //
BUSINESSWIRE
Nimble Tx Achieves Development Milestones From Multiple Partnered Programs
17 May 2022 //
BUSINESSWIRE
Nimble & Incyte Expand their Collaboration to Discover New Peptide Therapeutics
14 Sep 2021 //
BUSINESSWIRE
Nimble Therapeutics Appoints Cyrus Arman, PhD, MBA as Chief Business Officer
08 Sep 2021 //
BUSINESSWIRE
Nimble Therapeutics and RayzeBio Announce Strategic Research Collaboration
28 Jun 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.